5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 3.78▲ | 3.78▲ | 3.78▲ | 3.81▲ | 3.87▼ |
MA10 | 3.90▼ | 3.82▼ | 3.82▼ | 3.74▲ | 3.95▼ |
MA20 | 3.87▼ | 3.87▼ | 3.87▼ | 3.85▼ | 4.28▼ |
MA50 | 4.45▼ | 4.58▼ | 4.65▼ | 3.87▼ | 5.10▼ |
MA100 | 5.30▼ | 5.25▼ | 5.26▼ | 4.33▼ | 4.91▼ |
MA200 | 5.65▼ | 6.24▼ | 5.91▼ | 4.90▼ | 8.20▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.019▲ | 0.030▲ | 0.033▲ | 0.003▲ | -0.009▼ |
RSI | 45.697▼ | 45.134▼ | 44.697▼ | 49.321▼ | 41.793▼ |
STOCH | 44.388 | 42.369 | 42.369 | 43.762 | 41.136 |
WILL %R | -57.814 | -57.814 | -57.814 | -45.902 | -68.085 |
CCI | -21.561 | -33.364 | -33.364 | 32.651 | -66.853 |
Tuesday, June 10, 2025 01:03 AM
Molecular Partners (NASDAQ:MOLN) said that it has performed a strategic review of its current operations and headcount, with the objectives of increased efficiency in the organization and to sharpen ...
|
Monday, June 09, 2025 10:00 PM
LR Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics (“Molecular Partners” or the ...
|
Friday, May 30, 2025 06:20 AM
MOLN Molecular Partners AG Stock Price & Overview Follow $3.81 0.24 (+6.57%) 1:20 PM 05/30/25 ... Nasdaq Gold Bitcoin Market Outlook Today's Market US Economy Gold & Precious Metals Commodities ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/06/25 | 3.68 | 4.12 | 3.68 | 3.84 | 2,053 |
12/06/25 | 3.75 | 3.90 | 3.75 | 3.90 | 797 |
11/06/25 | 3.61 | 3.61 | 3.61 | 3.61 | 882 |
09/06/25 | 3.80 | 3.885 | 3.80 | 3.885 | 657 |
06/06/25 | 3.59 | 3.7992 | 3.58 | 3.7992 | 1,595 |
05/06/25 | 3.64 | 3.64 | 3.51 | 3.56 | 1,273 |
04/06/25 | 3.59 | 3.65 | 3.56 | 3.65 | 3,400 |
03/06/25 | 3.81 | 3.82 | 3.545 | 3.59 | 8,185 |
02/06/25 | 3.62 | 3.80 | 3.62 | 3.79 | 3,022 |
30/05/25 | 3.86 | 4.0793 | 3.8125 | 3.8125 | 2,473 |
|
|
||||
|
|
||||
|
|